Early-stage investor Artesian has made the first investment from its new female-led investment fund, deploying $3 million into a clinical trials software company called Evrima.is earmarked for Series A and B investments in high-growth female-led companies in Australia, New Zealand, South-East Asia and China.
“Being able to find patients, give them a good patient experience, and to meet clinical trial milestones on time and on budget was all a very cumbersome and manual process,” Ms Bradshaw told“In my role at that time my responsibility was to find eligible participants on time to meet very, very aggressive timelines. I distinctly remember working over the weekend to try and find eligible people by Monday morning because we had an extra couple of spots available.
The capital will enable the start-up to double its headcount and grow the capabilities of its tech platform.